ASX - By Stock
|
PYC |
Re:
Ann: Q3 2024 Investor Webinar Presentation
|
|
Medicine Man
|
17 |
6.2K |
38 |
30/08/24 |
30/08/24 |
ASX - By Stock
|
17
|
6.2K
|
38
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
Medicine Man
|
471 |
223K |
19 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
471
|
223K
|
19
|
|
ASX - By Stock
|
PYC |
Re:
News clipping
|
|
Medicine Man
|
10 |
5.6K |
27 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
10
|
5.6K
|
27
|
|
ASX - By Stock
|
PYC |
Re:
PYC Filed Another Patent
|
|
Medicine Man
|
35 |
23K |
26 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
35
|
23K
|
26
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Q2 2024 Investor Webinar Presentation
|
|
Medicine Man
|
23 |
7.4K |
25 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
23
|
7.4K
|
25
|
|
ASX - By Stock
|
PYC |
Re:
PYC Filed Another Patent
|
|
Medicine Man
|
35 |
23K |
32 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
35
|
23K
|
32
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
Medicine Man
|
174 |
81K |
19 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
174
|
81K
|
19
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
Medicine Man
|
174 |
81K |
35 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
174
|
81K
|
35
|
|
ASX - By Stock
|
PYC |
Re:
PYC Filed Another Patent
|
|
Medicine Man
|
35 |
23K |
37 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
35
|
23K
|
37
|
|
ASX - By Stock
|
PYC |
Re:
PYC Filed Another Patent
|
|
Medicine Man
|
35 |
23K |
47 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
35
|
23K
|
47
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
Medicine Man
|
471 |
223K |
31 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
471
|
223K
|
31
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Q1 2024 Investor Webinar Presentation
|
|
Medicine Man
|
10 |
4.8K |
18 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
10
|
4.8K
|
18
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Q1 2024 Investor Webinar Presentation
|
|
Medicine Man
|
10 |
4.8K |
11 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
10
|
4.8K
|
11
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
Medicine Man
|
174 |
81K |
15 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
174
|
81K
|
15
|
|
ASX - By Stock
|
PYC Biotech |
PYC Chart and Technical Analysis
|
|
Medicine Man
|
174 |
81K |
19 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
174
|
81K
|
19
|
|
ASX - By Stock
|
PYC |
Re:
PYC Filed Another Patent
|
|
Medicine Man
|
35 |
23K |
37 |
06/01/24 |
06/01/24 |
ASX - By Stock
|
35
|
23K
|
37
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
Medicine Man
|
471 |
223K |
23 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
471
|
223K
|
23
|
|
ASX - By Stock
|
PYC |
Re:
PYC Filed Another Patent
|
|
Medicine Man
|
35 |
23K |
27 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
35
|
23K
|
27
|
|
ASX - By Stock
|
PYC |
PYC Filed Another Patent
|
|
Medicine Man
|
35 |
23K |
29 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
35
|
23K
|
29
|
|
ASX - By Stock
|
PYC |
Re:
Ann: 2023 AGM Chairman's Address and CEO Presentation
|
|
Medicine Man
|
40 |
17K |
27 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
40
|
17K
|
27
|
|
ASX - By Stock
|
PYC |
Re:
Ann: 2023 AGM Chairman's Address and CEO Presentation
|
|
Medicine Man
|
40 |
17K |
27 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
40
|
17K
|
27
|
|
ASX - By Stock
|
PYC |
Re:
Ann: 2023 AGM Chairman's Address and CEO Presentation
|
|
Medicine Man
|
40 |
17K |
7 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
40
|
17K
|
7
|
|
ASX - By Stock
|
PYC |
Re:
Ann: 2023 AGM Chairman's Address and CEO Presentation
|
|
Medicine Man
|
40 |
17K |
49 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
40
|
17K
|
49
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Polycystic Kidney Disease Program Presentation
|
|
Medicine Man
|
10 |
5.3K |
25 |
18/11/23 |
18/11/23 |
ASX - By Stock
|
10
|
5.3K
|
25
|
|
ASX - By Stock
|
PYC |
Re:
Ann: New Drug For Major Kidney Disease Effective In Human Models
|
|
Medicine Man
|
56 |
19K |
22 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
56
|
19K
|
22
|
|
ASX - By Stock
|
PYC Biotech |
PYC 4th New Drug for Polycystic Kidney Disease
|
|
Medicine Man
|
0 |
827 |
27 |
10/10/23 |
10/10/23 |
ASX - By Stock
|
0
|
827
|
27
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Investor Presentation ADOA Program
|
|
Medicine Man
|
24 |
11K |
16 |
05/10/23 |
05/10/23 |
ASX - By Stock
|
24
|
11K
|
16
|
|
ASX - By Stock
|
PYC |
Re:
Ann: PYC-001 Effective In Both NHPs and Patient-Derived Models
|
|
Medicine Man
|
19 |
7.4K |
33 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
19
|
7.4K
|
33
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Q3 Investor Call Presentation
|
|
Medicine Man
|
16 |
6.2K |
14 |
02/10/23 |
02/10/23 |
ASX - By Stock
|
16
|
6.2K
|
14
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Q3 Investor Call Presentation
|
|
Medicine Man
|
16 |
6.2K |
7 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
16
|
6.2K
|
7
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Q3 Investor Call Presentation
|
|
Medicine Man
|
16 |
6.2K |
8 |
27/09/23 |
27/09/23 |
ASX - By Stock
|
16
|
6.2K
|
8
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Q3 Investor Call 27 September 2023
|
|
Medicine Man
|
20 |
6.1K |
9 |
27/09/23 |
27/09/23 |
ASX - By Stock
|
20
|
6.1K
|
9
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Q3 Investor Call 27 September 2023
|
|
Medicine Man
|
20 |
6.1K |
6 |
19/09/23 |
19/09/23 |
ASX - By Stock
|
20
|
6.1K
|
6
|
|
ASX - By Stock
|
PYC |
Re:
New valuation of PYC
|
|
Medicine Man
|
27 |
13K |
13 |
12/09/23 |
12/09/23 |
ASX - By Stock
|
27
|
13K
|
13
|
|
ASX - By Stock
|
PYC |
Re:
New valuation of PYC
|
|
Medicine Man
|
27 |
13K |
23 |
10/09/23 |
10/09/23 |
ASX - By Stock
|
27
|
13K
|
23
|
|
ASX - By Stock
|
PYC |
Re:
Valuing PYC
|
|
Medicine Man
|
89 |
37K |
21 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
89
|
37K
|
21
|
|
ASX - By Stock
|
PYC |
Re:
Ann: PYC Investor Update Presentation
|
|
Medicine Man
|
35 |
15K |
3 |
20/06/23 |
20/06/23 |
ASX - By Stock
|
35
|
15K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Valuing PYC
|
|
Medicine Man
|
89 |
37K |
5 |
01/06/23 |
01/06/23 |
ASX - By Stock
|
89
|
37K
|
5
|
|
ASX - By Stock
|
PYC |
Re:
PYC turns 2 corners
|
|
Medicine Man
|
44 |
18K |
18 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
44
|
18K
|
18
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Successful Completion of $30m Placement
|
|
Medicine Man
|
40 |
13K |
8 |
12/05/23 |
12/05/23 |
ASX - By Stock
|
40
|
13K
|
8
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Successful Completion of $30m Placement
|
|
Medicine Man
|
40 |
13K |
18 |
12/05/23 |
12/05/23 |
ASX - By Stock
|
40
|
13K
|
18
|
|
ASX - By Stock
|
PYC |
Re:
Ann: PYC Investor Update Presentation
|
|
Medicine Man
|
10 |
5.6K |
23 |
17/02/23 |
17/02/23 |
ASX - By Stock
|
10
|
5.6K
|
23
|
|
ASX - By Stock
|
PYC |
Re:
The Attractions of PYC's pipeline
|
|
Medicine Man
|
38 |
16K |
30 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
38
|
16K
|
30
|
|
ASX - By Stock
|
PYC |
Re:
The Attractions of PYC's pipeline
|
|
Medicine Man
|
38 |
16K |
20 |
11/02/23 |
11/02/23 |
ASX - By Stock
|
38
|
16K
|
20
|
|
ASX - By Stock
|
PYC |
Re:
Ann: PYC Corporate Presentation - February 2023
|
|
Medicine Man
|
15 |
6.6K |
27 |
04/02/23 |
04/02/23 |
ASX - By Stock
|
15
|
6.6K
|
27
|
|
ASX - By Stock
|
PYC |
Re:
FEBRUARY THE IND FDA Lodgement month
|
|
Medicine Man
|
4 |
1.9K |
7 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
4
|
1.9K
|
7
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Successful Toxicology Studies Pave Way for Human Trials
|
|
Medicine Man
|
99 |
45K |
23 |
14/01/23 |
14/01/23 |
ASX - By Stock
|
99
|
45K
|
23
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Central Nervous System Drug Program Added to PYC Pipeline
|
|
Medicine Man
|
37 |
17K |
4 |
20/10/22 |
20/10/22 |
ASX - By Stock
|
37
|
17K
|
4
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Central Nervous System Drug Program Added to PYC Pipeline
|
|
Medicine Man
|
37 |
17K |
6 |
20/10/22 |
20/10/22 |
ASX - By Stock
|
37
|
17K
|
6
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Central Nervous System Drug Program Added to PYC Pipeline
|
|
Medicine Man
|
37 |
17K |
16 |
20/10/22 |
20/10/22 |
ASX - By Stock
|
37
|
17K
|
16
|
|